According to a newly published market research report by 24LifeSciences, theglobal thymus cancer market was valued at USD 149 million in 2025 and is projected to reach USD 213 million by 2031, growing at a compound annual growth rate (CAGR) of 5.3% during the forecast period 2025–2031. Thymus cancer, clinically referred to as thymoma or thymic carcinoma, is a rare malignancy...